Neurocrine Switzerland GmbH clinical trials
A country office of Neurocrine Biosciences
The registry lists 2 studies whose lead sponsor is Neurocrine Switzerland GmbH. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 16, 2026.
Registry sponsor names on this page
- Neurocrine Switzerland GmbH2 studies
Something wrong with this grouping? Tell us on the Neurocrine Biosciences page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Neurocrine Biosciences studies →
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years OldRecruitingNCT07536269Phase 2
Sponsor listed in the registry: Neurocrine Switzerland GmbH
- Pharmacokinetics, Safety and Tolerability of Crinecerfont in Participants With Congenital Adrenal Hyperplasia Who Are Less Than 2 Years OldActive, not recruitingNCT07187375Phase 2
Sponsor listed in the registry: Neurocrine Switzerland GmbH